Physician profile
Arthur Selvan
NPI 1972507697
$1,448.33
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $440 · 2020: $269 · 2021: $527 · 2022: $165 · 2023: $31.06 · 2024: $16.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $47.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $47.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $507.18 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $249.03 | 2019-2021 | |
| Amgen INC. | $216.52 | 2019-2022 | |
| Pfizer INC. | $108.09 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $104.48 | 2019 | |
| Boston Scientific Corporation | $83.79 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $56.15 | 2022-2024 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $31.06 | 2023 | |
| Amarin Pharma, INC. | $24.08 | 2019 | |
| Medtronic Vascular, INC. | $22.53 | 2019 | |
| Astellas Pharma US INC | $18.22 | 2021 | |
| Bardy Diagnostics, INC. | $15.01 | 2019 | |
| Merck Sharp & Dohme LLC | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Selvan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.